Biotène Versus HydraSmile for Radiation-Induced Xerostomia: Randomized Double-Blind Cross-Over Study.

OTO Open · 2025 · PMC11696889 · PMID 39759943

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

a nonsignificant trendno p-value reported

In contrast, HydraSmile showed a nonsignificant trend towards outperforming Biotène with regard to overall symptomatic relief.

also in 5,406 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.